Most pharma firms doing little R&D for poorer patientsA ranking of pharma companies developing new medicines for low- and middle-income countries has revealed that just five Share XMost pharma firms doing little R&D for poorer patientshttps://pharmaphorum.com/news/most-pharma-firms-doing-little-rd-for-poorer-patients/
Increasing access to medicines: A critical look at pharmaceutical patentsExtending patents is restricting patients’ access to the treatments they need. Share XIncreasing access to medicines: A critical look at pharmaceutical patentshttps://pharmaphorum.com/views-and-analysis/increasing-access-to-medicines-a-critical-look-at-pharmaceutical-patents/
GSK leads on medicines access in developing countries, but room for improvementAccess to life-saving and life-changing medicines in poorer countries is improving year on year, but there is still Share XGSK leads on medicines access in developing countries, but room for improvementhttps://pharmaphorum.com/news/gsk-leads-medicines-access-developing-countries-room-improvement/